Balchem agrees to acquire vitamin K2 player Kappa Bioscience
New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
News, Analysis & Insights on Nutrition, Supplements, and Health
New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
There are just two weeks left to register for NutraIngredients Europe’s Immunity Webinar, which returns online at the end of this month.
Weight-loss testimonials "are not adequate substantiation" to prove diets work and specific food references require authorised health claims, the UK Advertising Standards Authority (ASA) has said in a guidance statement.
A daily omega-3 dose of between 2-3 grams per day has the most potential to lower blood pressure, according to a review of 71 studies.